Cargando…
Severe SARS-CoV-2 Infection in a Cat with Hypertrophic Cardiomyopathy
Coronavirus disease 19 (COVID-19), has claimed millions of human lives worldwide since the emergence of the zoonotic severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in China in December 2019. Notably, most severe and fatal SARS-CoV-2 infections in humans have been associated with underl...
Autores principales: | Carvallo, Francisco R., Martins, Mathias, Joshi, Lok R., Caserta, Leonardo C., Mitchell, Patrick K., Cecere, Thomas, Hancock, Sandy, Goodrich, Erin L., Murphy, Julia, Diel, Diego G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8402861/ https://www.ncbi.nlm.nih.gov/pubmed/34452375 http://dx.doi.org/10.3390/v13081510 |
Ejemplares similares
-
SARS-CoV-2 B.1.1.7 Variant Infection in Malayan Tigers, Virginia, USA
por: Mitchell, Patrick K., et al.
Publicado: (2021) -
Platelet Activation in Cats with Hypertrophic Cardiomyopathy
por: Tablin, F., et al.
Publicado: (2014) -
Symmetric Dimethylarginine in Cats with Hypertrophic Cardiomyopathy and Diabetes Mellitus
por: Langhorn, R., et al.
Publicado: (2017) -
Prominent J wave in cats with hypertrophic cardiomyopathy
por: ELSHARKAWY, Samar H., et al.
Publicado: (2021) -
Cardiac Troponin I and T as Prognostic Markers in Cats with Hypertrophic Cardiomyopathy
por: Langhorn, R., et al.
Publicado: (2014)